These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32409203)

  • 1. Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression.
    Sagris D; Leventis I; Georgiopoulos G; Korompoki E; Makaritsis K; Vemmos K; Milionis H; Lip GYH; Ntaios G
    Eur J Intern Med; 2020 Sep; 79():31-36. PubMed ID: 32409203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.
    Kyriakoulis I; Adamou A; Stamatiou I; Chlorogiannis DD; Kardoutsos I; Koukousaki D; Ntaios G
    Eur J Intern Med; 2024 Jan; 119():45-52. PubMed ID: 37648582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis.
    Boonyawat K; Caron F; Li A; Chai-Adisaksopha C; Lim W; Iorio A; Lopes RD; Garcia D; Crowther MA
    J Thromb Haemost; 2017 Jul; 15(7):1322-1333. PubMed ID: 28407368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
    Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
    Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.
    Gieling EM; van den Ham HA; van Onzenoort H; Bos J; Kramers C; de Boer A; de Vries F; Burden AM
    Br J Clin Pharmacol; 2017 Aug; 83(8):1844-1859. PubMed ID: 28205318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
    Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.
    Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A
    Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Differences in Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis.
    Raccah BH; Perlman A; Zwas DR; Hochberg-Klein S; Masarwa R; Muszkat M; Matok I
    Ann Pharmacother; 2018 Nov; 52(11):1135-1142. PubMed ID: 29681165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
    Makam RCP; Hoaglin DC; McManus DD; Wang V; Gore JM; Spencer FA; Pradhan R; Tran H; Yu H; Goldberg RJ
    PLoS One; 2018; 13(5):e0197583. PubMed ID: 29795629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.
    Huang WY; Singer DE; Wu YL; Chiang CE; Weng HH; Lee M; Ovbiagele B
    JAMA Neurol; 2018 Dec; 75(12):1511-1518. PubMed ID: 30105396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation - a network meta-analysis of real-world data.
    Hirschl M; Kundi M
    Vasa; 2019 Mar; 48(2):134-147. PubMed ID: 30376416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.
    Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta-analysis.
    Liu X; Huang M; Ye C; Xiao X; Yan C
    Clin Cardiol; 2021 Apr; 44(4):472-480. PubMed ID: 33682184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.